Oracle Investment Management Inc. Increases Stock Holdings in Forian Inc. (NASDAQ:FORA)

Oracle Investment Management Inc. increased its holdings in Forian Inc. (NASDAQ:FORA) by 0.7% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,366,107 shares of the company’s stock after acquiring an additional 10,000 shares during the quarter. Forian comprises about 1.5% of Oracle Investment Management Inc.’s investment portfolio, making the stock its 8th biggest holding. Oracle Investment Management Inc. owned about 4.40% of Forian worth $2,814,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of the business. Virtu Financial LLC bought a new stake in Forian in the 4th quarter worth about $30,000. Renaissance Technologies LLC raised its holdings in shares of Forian by 48.9% during the fourth quarter. Renaissance Technologies LLC now owns 35,301 shares of the company’s stock valued at $73,000 after purchasing an additional 11,601 shares during the last quarter. Finally, Elser Financial Planning Inc bought a new position in Forian during the fourth quarter valued at approximately $1,151,000. 19.25% of the stock is owned by hedge funds and other institutional investors.

Forian Stock Performance

FORA stock opened at $2.02 on Thursday. The company has a market cap of $63.01 million, a price-to-earnings ratio of -22.44 and a beta of 1.04. The business’s 50-day moving average is $2.02 and its two-hundred day moving average is $2.12. Forian Inc. has a fifty-two week low of $1.85 and a fifty-two week high of $4.03.

Insiders Place Their Bets

In other news, CEO Max C. Wygod bought 12,320 shares of Forian stock in a transaction that occurred on Tuesday, February 11th. The stock was bought at an average cost of $2.67 per share, with a total value of $32,894.40. Following the acquisition, the chief executive officer now owns 1,324,500 shares of the company’s stock, valued at $3,536,415. The trade was a 0.94 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 31.30% of the company’s stock.

About Forian

Forian Inc provides a suite of data management capabilities, and information and analytics solutions to optimize and measure operational, clinical, and financial performance for customers in the healthcare and related industries. It develops commercial, real world evidence (RWE), and market access solutions and proprietary data-driven insights, as well as offers data management solutions.